LAURUS LABS
|
The Current P/S Ratio of LAURUS LABS is 13.82.
| Share Price | ₹1,860.0 | Sep 01,2026 |
| Market Cap | ₹100,495.8 Cr | |
| Sales-TTM | ₹7,269.6 Cr | TTM-Consolidated Results |
| Price/Sales | 13.82x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of LAURUS LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹100,495.8 Cr] as on Sep 01,2026
(/) Sales [ ₹7,269.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 13.82x ]
Thus, for LAURUS LABS , the investors are currently willing to pay '13.82 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LAURUS LABS !
The chart below summarizes the trend in P/S Ratio of LAURUS LABS over the last five years.
Historical PS (Price/Sales) ratio chart of LAURUS LABS
PS Ratio Performance Analysis for LAURUS LABS
- LAURUS LABS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 5.41x.
- LAURUS LABS 's operated at median p/e ratio of 5.96x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LAURUS LABS 's p/e ratio peaked in Mar2026 at 7.86x.
- LAURUS LABS 's p/e ratio hit its five-year low in Mar2023 of 2.61x.
How does LAURUS LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| LAURUS LABS | 7,269.6 | 13.82 | 100,495.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.73 | 463,180.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.67 | 243,302.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.00 | 188,623.0 |
| CIPLA LTD | 28,324.4 | 4.04 | 114,554.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.94 | 97,741.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.61 | 97,467.0 |
| LUPIN LTD | 29,966.6 | 3.28 | 98,312.2 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.06 | 116,114.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.77 | 96,836.1 |
| BIOCON LTD | 17,321.1 | 3.78 | 65,391.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LAURUS LABS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.77x |
| Max industry PS | 21.67x |
| Median industry PS | 4.06x |
| Average industry PS | 7.52x |
You may also like the below Video Courses